Low expression of ANT1 confers oncogenic properties to rhabdomyosarcoma tumor cells via modulating metabolism and death pathways.
J. Vial, P. Huchede, S. Fagault, F. Basset, M. Rossi, J. Geoffray, J. Bisaccia, M. Creveaux, D. Neves, F. Fauvelle, P. Castets, M. Carre, K. Weber, M. Castets
This study shows that low ANT1 expression in rhabdomyosarcoma cells promotes oncogenic properties by altering metabolism and death pathways, and restoring ANT1 sensitizes cells to chemotherapy.
bioRxiv · Mar 3, 2020Cancer Biology